{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:11:54Z","timestamp":1755839514769,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00277-023-05221-6","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T06:02:16Z","timestamp":1681538536000},"page":"1459-1466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The presence of two light chain bands on immunofixation is associated with poor outcomes in newly diagnosed multiple myeloma patients"],"prefix":"10.1007","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1347-8332","authenticated-orcid":false,"given":"Ameni","family":"Jerbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Turki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Hachicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten","family":"Kallel Sarbeji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawsan","family":"Feki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Mejdoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaoula","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Ben Hmida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moez","family":"Elloumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"key":"5221_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clinbiochem.2017.05.001","volume":"51","author":"MAV Willrich","year":"2018","unstructured":"Willrich MAV, Murray DL, Kyle RA (2018) Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Clin Biochem 51:38\u201347. https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.05.001","journal-title":"Clin Biochem"},{"doi-asserted-by":"crossref","unstructured":"Morrison T, Booth RA, Hauff K, et al (2019) Laboratory assessment of multiple myeloma, 1st ed. Elsevier Inc","key":"5221_CR2","DOI":"10.1016\/bs.acc.2018.12.001"},{"key":"5221_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","volume":"120","author":"JJ Keats","year":"2012","unstructured":"Keats JJ, Chesi M, Egan JB et al (2012) Clonal competition with alternating dominance in multiple myeloma. Blood 120:1067\u20131076. https:\/\/doi.org\/10.1182\/blood-2012-01-405985","journal-title":"Blood"},{"key":"5221_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc3257","volume":"12","author":"GJ Morgan","year":"2012","unstructured":"Morgan GJ, Walker BA, Davies FE (2012) The genetic architecture of multiple myeloma. Nat Rev Cancer 12:335\u2013348. https:\/\/doi.org\/10.1038\/nrc3257","journal-title":"Nat Rev Cancer"},{"key":"5221_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/hon.2336","volume":"35","author":"I Avivi","year":"2017","unstructured":"Avivi I, Cohen YC, Joffe E et al (2017) Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome. Hematol Oncol 35:734\u2013740. https:\/\/doi.org\/10.1002\/hon.2336","journal-title":"Hematol Oncol"},{"key":"5221_CR6","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1182\/blood-2013-12-542662","volume":"123","author":"A Brioli","year":"2014","unstructured":"Brioli A, Giles H, Pawlyn C et al (2014) Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome. Blood 123:3414\u20133419. https:\/\/doi.org\/10.1182\/blood-2013-12-542662","journal-title":"Blood"},{"doi-asserted-by":"publisher","unstructured":"Liu N, Zhou H, Yang G, Geng C (2015) Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma. 930\u2013936. https:\/\/doi.org\/10.3892\/ol.2014.2750","key":"5221_CR7","DOI":"10.3892\/ol.2014.2750"},{"key":"5221_CR8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Anderson K, Gertz M et al (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467\u20131473. https:\/\/doi.org\/10.1038\/sj.leu.2404284","journal-title":"Leukemia"},{"key":"5221_CR9","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.2015.65.0044","volume":"34","author":"MA Dimopoulos","year":"2016","unstructured":"Dimopoulos MA, Sonneveld P, Leung N et al (2016) International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment. J Clin Oncol 34:1544\u20131557. https:\/\/doi.org\/10.1200\/JCO.2015.65.0044","journal-title":"J Clin Oncol"},{"key":"5221_CR10","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"5221_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BGM Durie","year":"2006","unstructured":"Durie BGM, Harousseau JL, Miguel JS et al (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467\u20131473. https:\/\/doi.org\/10.1038\/sj.leu.2404284","journal-title":"Leukemia"},{"key":"5221_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2007-01-067728","volume":"110","author":"F Van Rhee","year":"2007","unstructured":"Van Rhee F, Bolejack V, Hollmig K et al (2007) High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis. Blood 110:827\u2013832. https:\/\/doi.org\/10.1182\/blood-2007-01-067728","journal-title":"Blood"},{"key":"5221_CR13","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3892\/etm.2015.2352","volume":"9","author":"G Yang","year":"2015","unstructured":"Yang G, Geng C, Chen W (2015) Clinical characteristics of a group of patients with multiple myeloma who had two different \u03bb light chains by immunofixation electrophoresis\u202f: A retrospective study from a single center. Exp Therapeutic Med 9:1895\u20131900. https:\/\/doi.org\/10.3892\/etm.2015.2352","journal-title":"Exp Therapeutic Med"},{"key":"5221_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s12288-018-0926-0","volume":"34","author":"B Vani","year":"2018","unstructured":"Vani B, Ritu A, Praveen S et al (2018) Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern. Indian J Hematol Blood Trans 34:632\u2013635. https:\/\/doi.org\/10.1007\/s12288-018-0926-0","journal-title":"Indian J Hematol Blood Trans"},{"key":"5221_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12288-015-0605-3","volume":"32","author":"A Misra","year":"2016","unstructured":"Misra A, Mishra J, Chandramohan J et al (2016) Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma. Indian J Hematol Blood Trans 32:10\u201317. https:\/\/doi.org\/10.1007\/s12288-015-0605-3","journal-title":"Indian J Hematol Blood Trans"},{"doi-asserted-by":"publisher","unstructured":"Jerbi A, Hachicha H,  Charfi A,  Kallel F,  Feki S, Ben Ayed M, Ayadi F,  Akrout R,  Frikha F, Amouri A, Kammoun K,  Mdhaffar M,  Ben Hmida M, Tahri N,  Bahloul Z,  Baklouti S,  Elloumi M, Masmoudi H (2023) Biclonal Gammopathies in South Tunisia\u202f: Clinical and Biological Characteristics. Lab Med:6\u201310.  https:\/\/doi.org\/10.1093\/labmed\/lmac153","key":"5221_CR16","DOI":"10.1093\/labmed\/lmac153"},{"key":"5221_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.patbio.2004.01.014","volume":"53","author":"S Mseddi-hdiji","year":"2005","unstructured":"Mseddi-hdiji S, Haddouk S, Ben AM et al (2005) Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases. Pathol Biol (Paris) 53:19\u201325. https:\/\/doi.org\/10.1016\/j.patbio.2004.01.014","journal-title":"Pathol Biol (Paris)"},{"key":"5221_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.retram.2019.11.003","volume":"68","author":"R Belouni","year":"2020","unstructured":"Belouni R, Allam I, Cherguelaine K et al (2020) Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria. Curr Res Transl Med 68:67\u201370. https:\/\/doi.org\/10.1016\/j.retram.2019.11.003","journal-title":"Curr Res Transl Med"},{"doi-asserted-by":"crossref","unstructured":"Joan Blade\u00b4 Rakaprgd (1996) Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. British Journal ofHaematology 345\u2013351","key":"5221_CR19","DOI":"10.1046\/j.1365-2141.1996.5191061.x"},{"key":"5221_CR20","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1200\/JCO.1994.12.11.2398","volume":"12","author":"BJ Blad","year":"1994","unstructured":"Blad BJ, Lust JA, Kyle RA (1994) Immunoglobulin D Multiple Myeloma: Presenting Features, Response to Therapy, and Survival in a Series of 53 Cases. J Clin Oncol 12:2398\u20132404","journal-title":"J Clin Oncol"},{"key":"5221_CR21","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1038\/leu.2008.131","volume":"22","author":"MA Dimopoulos","year":"2008","unstructured":"Dimopoulos MA, Kastritis E, Rosinol L, Blad\u00e9 J, Ludwig H (2008) Pathogenesis and treatment of renal failure in multiple myeloma \u00b4 2. Leukemia 22:1485\u20131493. https:\/\/doi.org\/10.1038\/leu.2008.131","journal-title":"Leukemia"},{"key":"5221_CR22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/labmed\/lmaa057","volume":"4","author":"S Gurmukh","year":"2021","unstructured":"Gurmukh S, Xu H (2021) Light Chain Predominant Intact Immunoglobulin Monoclonal Gammopathy Disorders: Shorter Survival in Light Chain Predominant Multiple Myelomas. Lab Med 4:390\u2013398. https:\/\/doi.org\/10.1093\/labmed\/lmaa057","journal-title":"Lab Med"},{"key":"5221_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/labmed\/lmab054","volume":"53","author":"G Singh","year":"2022","unstructured":"Singh G, Savage NM, Jillella AP, Bollag RJ (2022) Light Chain-Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival. Lab Med 53:145\u2013148. https:\/\/doi.org\/10.1093\/labmed\/lmab054","journal-title":"Lab Med"},{"key":"5221_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","volume":"14","author":"S Manier","year":"2016","unstructured":"Manier S, Salem KZ, Park J et al (2016) Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol 14:100\u2013113. https:\/\/doi.org\/10.1038\/nrclinonc.2016.122","journal-title":"Nat Rev Clin Oncol"},{"key":"5221_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV (2020) Multiple myeloma\u202f: 2020 update on diagnosis, risk-stratification and management. Am J Hematol 95:548\u2013567. https:\/\/doi.org\/10.1002\/ajh.25791","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05221-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05221-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:18:01Z","timestamp":1683886681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05221-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["5221"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05221-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"27 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Because this was a retrospective study, the requirement for informed consent was not possible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial interest"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}